Industry News
Health In Tech Announces Third Quarter 2025 Financial Results
* Revenue reached $8.5 million, up 90% year over year; nine-month revenue totaled$25.8 million, representing 132% of full-year 2024 total revenue. * Adjusted EBITDA was $1.0 million, an increase of 49% year over year; nine-month adjusted EBITDA reached$3.8 million, or 167% of full-year 2024 to...
Matter 1.4 Elevates the Linkind Smart Bulb Experience
LOS ANGELES, Nov. 10, 2025 /PRNewswire/ -- Linkind
LiberNovo Launches Black Friday Savings: Redefine Your Workspace for Health
HONG KONG, Nov. 10, 2025 /PRNewswire/ -- The season for serious deals has
arrived, and LiberNovo today launched its Black Friday & Cyber Monday (BFCM)
sale across across the U.S. and Canada—with limited-time discounts of up to 34%
on its flagship product,the LiberNovo Omni
TORRAS Introduces OrigArmor: The Next Generation of Anti-Reflective Screen Protection, Now Available for Black Friday
LOS ANGELES, Nov. 10, 2025 /PRNewswire/ -- As Black Friday approaches, TORRAS, the tech brand known for blending minimalist design with precision engineering, is unveiling its most advanced screen protector yet —OrigArmor. Designed specifically for the latest iPhone 17 and 16 series, OrigArmor is...
WKBC 2025: CLEARCHANG Highlights Korean Engineering Excellence in Air Purifier and Indoor Air Purification Systems
In Atlanta, CLEARCHANG's window-mounted air purifier demonstrated the synergy of design, ventilation, and sustainable indoor air purification. SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ -- CLEARCHANG Co., Ltd., a pioneer in advancedair purifier and ventilation technology, successfully partic...
Phrozen Presents ARCO: Fast, Full-Color FDM 3D Printing for Creative Minds
TAIPEI, Nov. 10, 2025 /PRNewswire/ -- Phrozen
TGE Pursues the Acquisition of the 100th Ritz Carlton Hotel Globally
PARIS, NEW YORK and SINGAPORE, Nov. 10, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that TGE has entered into ...
CLEARCHANG Unveils "Rebreeze" at CES 2025 -- Redefining Indoor Air Standards with a Smart Window-Mounted Air Purifier
Powered by nano-fiber filtration and AI control technology, Rebreeze delivers cleaner and fresher air through intelligent ventilation. SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ -- As global interest in air quality and sustainable living continues to rise, CLEARCHANG Co., Ltd. unveiled its i...
TIME's Best Invention Winner iGarden Swim Jet P Series Officially Launches, Setting a New Standard in Home Pool Entertainment
LOS ANGELES, Nov. 10, 2025 /PRNewswire/ -- Fresh from being named one of TIME's Best Inventions of 2025, iGarden is proud to announce the official launch of its AI-powerediGarden Swim Jet P Series, marking a significant leap in smart pool technology. Engineered with proprietary AI-driven systems,...
New Research from UpGuard Reveals 68% of Security Leaders Admit to Unauthorized AI Usage
The study also shows 8 out of 10 employees use unauthorized AI, eroding
corporate trust
MOUNTAIN VIEW, Calif., Nov. 10, 2025 /PRNewswire/ -- UpGuard
APAC Threat Intelligence Latest Insights: 79% of Enterprises to Increase Investment in Threat Intelligence
BEIJING, Nov. 10, 2025 /PRNewswire/ -- As a professional media outlet focused on innovative services within the data intelligence industry, DataYuan consistently tracks the deep integration of new technologies like AI and cloud computing with data applications. With the widespread application of ...
Tiumbio to Present First Clinical Data for Dual TGF-β/VEGF Inhibitor Tosposertib (TU2218) at SITC 2025, "Robust Response Rate"
* 70.6% Partial Response and 82.4% Disease Control Rate Observed in Interim Phase II Data SEONGNAM, South Korea, Nov. 10, 2025 /PRNewswire/ -- On Friday, 7 November (local time) at the Society for Immunotherapy of Cancer (SITC) 2025 annual meeting, Tiumbio Co., Ltd. (KOSDAQ: 321550), a clinical...
MicroCloud Hologram Inc. Explores Unlocking the Quantum Codes of Time and Systems
SHENZHEN, China, Nov. 10, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, focuses on conquering deep-level problems in the field of quantum technology, committed to injecting new vitality into global technological development...
iTeaworld Launches the World's First Structured "Yin Zhi" Scented Tea Collections -- Reimagining a Millennium-Old Chinese Craft
SHENZHEN, China, Nov. 10, 2025 /PRNewswire/ -- Following the enthusiastic
response to iTeaworld's Oolong Tea Framework at the 2025 Northwest Tea Festival,
iTeaworld
Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo
BOSTON, Nov. 10, 2025 /PRNewswire/ -- Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo duringNovember 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostics that power qPCR/RT-qPCR, Isothermal Amplification, and Next-...
Simcere's IL-2 Mutant Fusion Protein SIM0278 Entered Phase II Clinical Trial Stage
NANJING, China, Nov. 10, 2025 /PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK) announced that its regulatory T cells(Treg)-preferential IL-2 mutant Fc fusion protein (IL-2 mu-Fc), SIM0278, has officially entered a Phase II clinical study inChina for the treatment of moderate-to-severe atopi...
Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech
BEIJING, Nov. 10, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced it has entered into a patent license agreement with Shandong Shunfeng Biotechnology Co., Ltd. ("Shunfeng BioTech") for the Cas...
LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)
SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ -- LISCure Biosciences
Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monotherapy or in Combination with Cadonilimab or Ivonescimab for Adjuvant Treatment of Pancreatic Cancer
HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vaccine AK154. This trial is investigating AK154 both as a monotherapy and as a combination with the com...
DFRobot UNIHIKER K10 Crowned Winner in Teach Secondary's EdTech & Software Category at 2025 TeachCo Resource Awards
SHANGHAI, Nov. 10, 2025 /PRNewswire/ -- DFRobot
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 319 media titles]
2026-01-23 11:03Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 317 media titles]
2026-01-29 15:06Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 309 media titles]
2026-01-27 13:00UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 307 media titles]
2026-01-23 09:00Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 294 media titles]
2026-01-27 18:00